Familial neurocardiogenic syncope is a syndrome characterized by brief loss of consciousness caused by dysfunction of the autonomic nervous system, resulting in low blood pressure and slow heart rate. The condition most often occurs in young adults and may be hereditary. Patients often experience episodes of syncope in response to various triggers, such as stress, pain, prolonged standing, and overheating or dehydration. The condition may be caused by a combination of genetic factors and environmental circumstances, making it unique from other forms of syncope.
History of the disease and interesting historical facts
The history of neurocardiogenic syncope has deep roots, dating back to ancient times, when physicians attempted to explain the loss of consciousness. Ancient Roman and Greek physicians described similar symptoms, but it was not until the 19th century that the concept of neurovegetative dysfunction as a cause of syncope emerged. The first observations of familial cases were documented in the early 20th century, which gave rise to more detailed studies. In particular, the English cardiologist Sir Thomas Browne linked genetic inheritance to forms of syncope containing neurocardiogenic mechanisms in the 1920s.
Epidemiology
According to various epidemiological studies, familial neurocardiogenic syncope occurs in 15-20% of the population, although the clinical manifestation may vary. The overall number of cases affects the young population, most often people aged 10 to 30 years. Population analysis shows that syncope may occur in 7% school-age children, but only in 2% of them was a link established with hereditary factors. These statistics emphasize the importance of early diagnosis and consideration of genetic predisposition.
Genetic predisposition to this disease
Recent studies have revealed that several genes may be involved in the development of familial neurocardiogenic syncope. Genetic mutations associated with abnormalities in the coding of proteins that affect the function of the autonomic nervous system include mutations in the SCN5A and KCNQ1 genes. These mutations may lead to functional abnormalities in the regulation of heart rhythm and conduction. In addition, family studies indicate that the inherited pattern of transmission may be either autosomal dominant or recessive, depending on the specific genetic mutation.
Risk factors for the development of this disease
Risk factors associated with familial neurocardiogenic syncope can vary, but the main ones include:
- Physical factors:
- Stress and emotional stress
- Standing or sitting for long periods of time
- Dehydration and overheating
- Chemical factors:
- Use of certain medications (eg, antidepressants)
- Use of alcohol or drugs
- Other factors:
- Family history of neurocardiogenic syncope
- Associated diseases affecting the cardiovascular system
Diagnosis of this disease
Diagnosis of familial neurocardiogenic syncope is based on a thorough clinical examination of the patient and includes the following steps:
- Main symptoms:
- Brief loss of consciousness
- Signs of fainting, such as dizziness and blurred vision
- Laboratory tests:
- Complete blood count and biochemistry to rule out other diseases
- Determination of electrolyte levels
- Radiological examinations:
- ECG to assess heart rhythm and detect abnormalities
- Holter monitoring for recording fainting episodes in everyday life
- Other types of disease diagnostics:
- Postural tests to determine the response to changes in body position
- Reflex tests to assess autonomic nervous system function
- Differential diagnosis:
- It is important to rule out conditions such as epilepsy or cardiac arrhythmias
- Fainting associated with metabolic disorders must also be taken into account.
Treatment
Treatment of neurocardiogenic syncope includes a comprehensive approach that takes into account the individual characteristics of the patient:
- General treatment:
- Educating the patient and family about the mechanisms of the disease and triggers for syncope
- Lifestyle changes, including maintaining adequate hydration and avoiding known triggers
- Pharmacological treatment:
- Use of beta blockers to control heart rate and blood pressure
- Medications that improve venous outflow, such as fludrocortisone
- Surgical treatment:
- In some cases, if conservative treatment is ineffective, pacemaker implantation may be considered.
- Other types of treatment:
- Physiotherapy and rehabilitation to improve the body's ability to adapt to stressful situations
- Psychotherapy for working with emotional factors
List of medications used to treat this disease
The main drugs used to treat familial neurocardiogenic syncope include:
- Beta blockers: propranolol, atenolol
- Fludrocortisone
- Antidepressants: Selective serotonin reuptake inhibitors (SSRIs)
- Preparations that improve microcirculation: Trental
Disease monitoring
Monitoring the dynamics of the disease includes regular visits to the doctor and follow-up examinations. The prognosis of the disease is usually favorable, but some complications are possible:
- Possible exacerbations and development of more serious arrhythmias
- Psychological aspects such as fear of repeated episodes of loss of consciousness
Regular monitoring and support from healthcare professionals play an important role in managing the patient's condition.
Age-related features of the disease
Familial neurocardiogenic syncope may present differently depending on age. In children and adolescents, syncope is more often associated with physical activity or stress, while in adults, drug reactions and comorbidities may be more pronounced. In older adults, special attention should be paid to other cardiovascular diseases that may worsen the manifestations of neurocardiogenic syncope.
Questions and Answers
- What are the main symptoms of familial neurocardiogenic syncope?
Answer: The main symptoms include loss of consciousness, dizziness, darkening of the vision and a feeling of lightheadedness. - What factors can trigger fainting?
Answer: Fainting can be caused by stress, prolonged standing, overheating and dehydration. - How is this disease diagnosed?
Answer: Diagnosis includes anamnesis, clinical examination, ECG, monitoring and, if necessary, additional studies. - What are the main treatment methods?
Answer: Treatment may include lifestyle changes, drug therapy, physical therapy rehabilitation, and in rare cases, surgery. - What is the prognosis for this disease?
Answer: The prognosis is generally favorable, but it is important to monitor the condition and take preventive measures.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov advises paying attention to the following:
— Learn the triggers of fainting and try to avoid them. This will help reduce the frequency of episodes.
— Don't forget about regular physical activity, but avoid heavy training without first saturating the body with liquid.
— Try to minimize stressful situations and work on your psychological state, as this is of great importance for your health.
— Before starting any drug therapy, be sure to consult with your doctor to choose the best approach based on your individual characteristics and health condition.
